Skip to content

Compound reference

Melanotan II: structure and analysis

Melanocortin analog. What the molecule is, how it is made, and what an analytical certificate for it can and cannot establish.
Written by [[CONTENT AUTHOR NAME]]Reviewed by [[SCIENTIFIC REVIEWER NAME]], [[REVIEWER CREDENTIALS]]Updated Editorial policy

What it is

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone. Seven residues, closed into a ring rather than left as a linear chain.

The cyclisation is the defining structural feature. A covalent bridge joins two points in the sequence, constraining the molecule into a fixed conformation instead of the flexible chain a linear peptide of the same length would be.

How it is produced

Assembled by solid-phase peptide synthesis: the chain is built one residue at a time on an insoluble resin support, then cleaved from the resin, deprotected and purified — most commonly by reversed-phase high-performance liquid chromatography. The purified material is lyophilized to a dry solid.

The impurity profile that appears on a certificate is a record of where that process was imperfect: deletion sequences from an incomplete coupling, truncated chains, and species retaining a protecting group.

Confirming identity

Ring closure is what mass spectrometry confirms here beyond the sequence itself. Forming the bridge eliminates a small molecule — water, in the case of a lactam — so the cyclic product has a lower mass than the linear precursor by a predictable amount.

That makes the linear, uncyclised species a detectable and distinct impurity rather than an invisible one. It is the specific thing an identity result on this compound should settle.

Analytical considerations

Cyclic and linear forms of the same sequence usually separate well chromatographically, because the constrained conformation changes how the molecule interacts with the stationary phase. The uncyclised precursor is therefore both mass-distinguishable and retention-distinguishable, which is a favourable analytical position.

Conformational constraint also confers real stability: a cyclic peptide is a poorer substrate for proteases than its linear counterpart, since the enzyme requires a degree of backbone flexibility to bind.

PT-141 is structurally a metabolite of this compound and the two are closely related. Distinguishing them requires attention to a small mass difference, which makes the resolution of the identity method a genuine consideration.

What its certificate reports

A certificate for a lot of this material names the lot, names the issuing laboratory, and states for each parameter both the method used and the specification the result was measured against. Identity and purity are the two core results; net peptide content states how much of the fill weight is actually peptide.

A certificate belongs to a lot, not to a product line. When a new lot is released it is tested again, and the certificate published against it is that lot's certificate — a previous lot's result is never carried forward.

Research use only

This page describes structure and analysis. It makes no claim about what this compound does, and none should be inferred from it. Material is supplied for laboratory research use only: it is not a drug, food, dietary supplement, cosmetic or medical device, it is not for human or veterinary consumption, and no dosing, administration or reconstitution guidance is provided for any such use.

From the catalog

Compounds referenced on this page

For laboratory research use only. Not for human or veterinary consumption.